NHLBI Workshop on Future Directions for Hypertension Treatment Trials

List of Participants

 Executive Summary          Agenda


*Robert M. Califf, M.D.
(Workshop Chairman)
Professor of Medicine
Associate Vice Chancellor for Clinical Research
Duke Clinical Research Institute

Michael H. Alderman, M.D.
Professor of Epidemiology and Population Health
Albert Einstein College of Medicine

Donna K. Arnett, Ph.D.
Professor of Epidemiology
Mayo Professor of Public Health
Division of Epidemiology
University of Minnesota

George L. Bakris, M.D.
Professor of Preventive Medicine and Internal Medicine
Rush Medical University

Henry R, Black, M.D.
Associate VP for Research
Chairman, Department of Preventive Medicine
Rush-Presbyterian-St. Luke’s Medical Center

Eric Boerwinkle, M.S., Ph.D.
Professor and Center Director
University of Texas Health Science Center at Houston

*William C. Cushman, M.D.
Professor, Preventive Medicine
University of Tennessee Health Sciences Center
Chief, Preventive Medicine
VA Medical Center (Memphis)

Barry R. Davis, M.D., Ph.D.
Professor of Biostatistics
University of Texas School of Public Health

Richard B. Devereux, M.D. (via telephone)
Professor of Medicine
New York Presbyterian Hospital
Weill Cornell Medical Center

Professor Albert Fournier
HOSPITAL SUD
Department of Nephrology
AMIENS
France

Curt D. Furberg, M.D., Ph.D.
Professor
Wake Forest University School of Medicine

Thomas D. Giles, M.D.
Professor of Medicine
Louisiana State University Medical School

John S. Gottdiener, M.D.
Director, Non-Invasive Cardiac Imaging
Saint Francis Hospital (New York City)

Richard H. Grimm, Jr., M.D., Ph.D.
Professor, Cardiology and Epidemiology
University of Minnesota
Berman Center for Outcomes and Clinical Research
Hennepin County Medical Center

David J. Hyman, M.D., M.P.H.
Associate Professor
Baylor College of Medicine

John B. Kostis, M.D.
Professor of Medicine and Pharmacology
University of Medicine and Dentistry of New Jersey
Robert Wood Johnson Medical School

Ronald M. Krauss, M.D.
Director, Atherosclerosis Research
Childrens’ Hospital Oakland Research Institute
Senior Scientist, Dept. of Genome Science, LBNL
Adjunct Professor, Dept. of Nutritional Sciences, UC Berkeley

Andrew S. Levey, M.D.
Chief, William B. Schwartz, MD Division of Nephrology
Department of Medicine
Tufts – New England Medical Center

Stephen MacMahon, Ph.D.
Professor of Cardiovascular Medicine
Institute for International Health (present name: The George Institute)
University of Sydney
Australia

Suzanne Oparil, M.D.
Director, Vascular Biology and Hypertension Program
Division of Cardiovascular Disease
University of Alabama at Birmingham

Jeffrey L. Probstfield, M.D., FACP, FACC
Director, Clinical Trials Service Unit
Professor of Medicine (Cardiology)
Adjunct Professor of Epidemiology
University of Washington School of Medicine

Bruce M. Psaty, M.D., Ph.D.
Professor of Medicine and Epidemiology
Cardiovascular Health Research Unit
University of Washington

*Laura Svetkey, M.D., MHS
Professor of Medicine
Duke University Medical Center

Robert Temple, M.D.
Associate Director for Medical Policy
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

*Douglas Throckmorton, M.D.
Director, Division of Cardiorenal Drugs
U.S. Food and Drug Administration

Stephen T. Turner, M.D.
Professor of Medicine
Mayo Clinic Rochester

*Jackson Wright, M.D., Ph.D.
Professor of Medicine
Case Western Reserve University

(*Planning Committee)

August 2004

Skip footer links and go to content
Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon